Physician

Amparo Leilah Gordian, MD

According to 2025 Medicare claims, Amparo Gordian, MD (NPI: 1205039997) practices rheumatology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Manatee, FL. This provider's primary affiliated billing organization is WEITZNER YONKER & KAINE MD PA (NPI: 1659358927; TIN: 591842511) and primary practice location at 34203-9781. Gordian is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Gordian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 864 traditional Medicare patients, billed 313,297 HCPCS/CPT codes, and received $3,716,817 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,655 prescription claims across 308 beneficiaries totaling $634,146 in drug costs, led by Cosentyx Sensoready Pen (Secukinumab). 2020 DME data shows 11 claims. Open Payments data shows 142 records totaling $2,917. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $130,757 to $3,716,817. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $426,561 and ending at $634,146. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.